A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Intravenous TP-271 in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Aug 2017
At a glance
- Drugs TP 271 (Primary)
- Indications Bacterial infections; Community-acquired pneumonia; Pneumonia
- Focus Adverse reactions
- Sponsors Tetraphase Pharmaceuticals
- 02 Aug 2017 According to a Tetraphase Pharmaceuticals media release, the company anticipates to complete this study in the year 2017.
- 31 Jul 2017 Status changed to recruiting.
- 14 Mar 2017 New trial record